US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apimeds Pharmaceutical U.S, Inc.

5.00

-0.0200-0.40%

Post-market: 4.84-0.1600-3.20%19:55 EDT

Volume:191.10K

Turnover:955.48K

Market Cap:7.55M

PE:-0.13

High:5.25

Open:5.04

Low:4.72

Close:5.02

52wk High:59.70

52wk Low:1.51

Shares:1.51M

Float Shares:725.94K

Volume Ratio:0.01

T/O Rate:26.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-38.5450

EPS(LYR):-0.1759

ROE:-144.99%

ROA:-69.29%

PB:0.92

PE(LYR):-28.43

Loading ...

Overview Company News Filings

MindWave expands blockchain services into sports media markets

Apimeds Unit MindWave Innovations to Deploy MindChain Blockchain for AQUAEChain Platform

Mindwave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate Flashchain for New York-Based Flash Sports & Media

THOMSON REUTERS

Mindwave Innovations: Parties Have not Publicly Disclosed Aggregate Dollar Value of Consideration Under Agreement.

THOMSON REUTERS

Amex Halt Add Info Lst 7.920000

THOMSON REUTERS

Top Midday Gainers

MT Newswires Live

Why Is Apimeds Pharmaceuticals US Stock (APUS) Up Today?

Mindwave Innovations Signs Agreement to Build and Operate Aquaechain, a Platform for Insured Alci Credits

THOMSON REUTERS

Apimeds Pharmaceuticals US - Enters First Amendment to Settlement Agreement on Sept 10, 2026 - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US - Board to Consist Solely of Four Members During Interim Period - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US - Board to Expand to Seven Members After Interim Period - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals Adds Co-CEO Sungjoon Chae to Board

Apimeds Pharmaceuticals US Enters Assignment and Transfer Agreement with Freet on August 19

Apimeds Secures Key Apitox Rights via FreeT Agreement

Apimeds Pharmaceuticals US - Freet Assigns All Apitox-Related Rights to Apimeds Pharmaceuticals - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US - Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation for Apitox - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US Gains Apitox Rights in Assignment from South Korea’s FreeT

Apimeds Net Loss Widens to $20.17 Million in Q2 2026; R&D Expenses Rise 47% to $959,742 vs Year-Ago Quarter

Apimeds Pharmaceuticals Names Christopher Kim Chief Scientific Officer

Apimeds Appoints Chief Scientific Officer to Advance APITOX

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/APUS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":5,"timestamp":1790798400000,"preClose":5.02,"halted":0,"volume":191095,"hourTrading":{"tag":"盘后","latestPrice":4.84,"preClose":5,"latestTime":"19:55 EDT","volume":4327,"amount":21193.9288,"timestamp":1790812514931,"change":-0.16,"changeRate":-0.032,"amplitude":0.032},"delay":0,"changeRate":-0.003984063745019836,"floatShares":725942,"shares":1509119,"eps":-38.545,"marketStatus":"Not Yet Opened","change":-0.02,"latestTime":"09-30 16:00:00 EDT","open":5.04,"high":5.25,"low":4.72,"amount":955475,"amplitude":0.105578,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-38.545,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":5.02,"preHourTrading":{"tag":"盘前","latestPrice":4.81,"preClose":5.02,"latestTime":"09:28 EDT","volume":3281,"amount":15763.716738400002,"timestamp":1790774932015,"change":-0.21,"changeRate":-0.041833,"amplitude":0.069721},"postHourTrading":{"tag":"盘后","latestPrice":4.84,"preClose":5,"latestTime":"19:55 EDT","volume":4327,"amount":21193.9288,"timestamp":1790812514931,"change":-0.16,"changeRate":-0.032,"amplitude":0.032},"volumeRatio":0.007539},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":725942,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":0.007539,"shares":1509119,"dividePrice":0,"high":5.25,"amplitude":0.105578,"preClose":5.02,"low":4.72,"week52Low":1.51,"pbRate":"0.92","week52High":59.7,"institutionHeld":0,"latestPrice":5,"eps":-38.545,"divideRate":0,"volume":191095,"delay":0,"ttmEps":-38.545,"open":5.04,"prevYearClose":16.4,"prevWeekClose":7.25,"prevMonthClose":3.88,"prevQuarterClose":9,"fiveDayClose":2.29,"twentyDayClose":3.54,"sixtyDayClose":7.425},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-24","symbol":"APUS","defaultRemindTime":1784899800000,"type":"split","dateTimestamp":1784865600000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-0.129719,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1790834496622},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APUS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671291247","title":"MindWave expands blockchain services into sports media markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2671291247","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671291247?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:52","pubTimestamp":1790715149,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US, Inc. ( ($APUS) ) just unveiled an announcement. On September 24, 2026, MindWave Innovations Inc., a subsidiary of Apime...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mindwave-expands-blockchain-services-into-sports-media-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mindwave-expands-blockchain-services-into-sports-media-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HECO","BK4139","APUS","BKCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671242723","title":"Apimeds Unit MindWave Innovations to Deploy MindChain Blockchain for AQUAEChain Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2671242723","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671242723?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:16","pubTimestamp":1790712993,"startTime":"0","endTime":"0","summary":"Apimeds unit MindWave Innovations to deploy MindChain blockchain for AQUAEChain platformMindWave Innovations, a unit of Apimeds Pharmaceuticals US, signed a 12-month technology services deal with AQUA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL4pfpGw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671952214","title":"Mindwave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate Flashchain for New York-Based Flash Sports & Media","url":"https://stock-news.laohu8.com/highlight/detail?id=2671952214","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671952214?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:33","pubTimestamp":1790685180,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0OH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671214954","title":"Mindwave Innovations: Parties Have not Publicly Disclosed Aggregate Dollar Value of Consideration Under Agreement.","url":"https://stock-news.laohu8.com/highlight/detail?id=2671214954","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671214954?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:33","pubTimestamp":1790685180,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0OH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670428648","title":"Amex Halt Add Info Lst 7.920000","url":"https://stock-news.laohu8.com/highlight/detail?id=2670428648","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670428648?lang=en_us&edition=fundamental","pubTime":"2026-09-25 21:39","pubTimestamp":1790343587,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nAQN2MKV1I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670497682","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670497682","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670497682?lang=en_us&edition=fundamental","pubTime":"2026-09-25 01:46","pubTimestamp":1790272002,"startTime":"0","endTime":"0","summary":"Everpure (P) reaffirmed fiscal 2027 adjusted operating income guidance of $940 million to $960 million on revenue of $5.03 billion to $5.07 billion late Wednesday. FactSet-polled analysts expect $959.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","PUL","TJGC","LU0154245756.USD","LU0154245673.USD","P","BK4585","APUS","BK4170","BK4009","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492938","title":"Why Is Apimeds Pharmaceuticals US Stock (APUS) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492938?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:39","pubTimestamp":1790267961,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US stock rallied after the company reached a deal with AQUAE to manage AQUAEChain.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-apimeds-pharmaceuticals-us-stock-apus-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-apimeds-pharmaceuticals-us-stock-apus-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669749832","title":"Mindwave Innovations Signs Agreement to Build and Operate Aquaechain, a Platform for Insured Alci Credits","url":"https://stock-news.laohu8.com/highlight/detail?id=2669749832","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669749832?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:30","pubTimestamp":1790253028,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666522022","title":"Apimeds Pharmaceuticals US - Enters First Amendment to Settlement Agreement on Sept 10, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666522022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666522022?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:11","pubTimestamp":1789132313,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN45306Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666220035","title":"Apimeds Pharmaceuticals US - Board to Consist Solely of Four Members During Interim Period - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666220035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666220035?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:11","pubTimestamp":1789132313,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN45306Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666006522","title":"Apimeds Pharmaceuticals US - Board to Expand to Seven Members After Interim Period - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666006522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666006522?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:11","pubTimestamp":1789132313,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN45306Z:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666152207","title":"Apimeds Pharmaceuticals Adds Co-CEO Sungjoon Chae to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2666152207","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666152207?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:11","pubTimestamp":1789132287,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals adds Co-CEO Sungjoon Chae to boardApimeds Pharmaceuticals US amended a settlement to reset board control ahead of a preferred stock conversion.Interim board set at four directo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL1Kss6C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226290","title":"Apimeds Pharmaceuticals US Enters Assignment and Transfer Agreement with Freet on August 19","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226290","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226290?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:31","pubTimestamp":1787347904,"startTime":"0","endTime":"0","summary":"BRIEF-Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19Aug 21 -Apimeds Pharmaceuticals US IncAPUS.A:APIMEDS PHARMACEUTICALS US - ENTERS ASSIGNMENT AND TRANSFER AGREEMENT WITH FREET ON AUG 19, 2026 - SEC FILINGAPIMEDS PHARMACEUTICALS US - FREET ASSIGNS ALL APITOX-RELATED RIGHTS TO APIMEDS PHARMACEUTICALS - SEC FILINGAPIMEDS PHARMACEUTICALS US - RECEIVES 100% KOREAN CLINIC RIGHTS, 25% U.S. ROYALTY, 25% OVERSEAS REVENUE PARTICIPATION FOR APITOX - SEC FILINGAPIMEDS PHARMACEUTICALS US - ASSIGNED RIGHTS ARE FREE AND CLEAR OF PRIOR CLAIMS OR ENCUMBRANCES - SEC FILINGSource text: [ID:n0001213900-26-092680]Further company coverage:APUS.A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661907092","title":"Apimeds Secures Key Apitox Rights via FreeT Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661907092","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661907092?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:27","pubTimestamp":1787347671,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Apimeds Pharmaceuticals US, Inc. ( ($APUS) ). On August 19, 2026, Apimeds Pharmaceuticals US, Inc. entered into...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apimeds-secures-key-apitox-rights-via-freet-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apimeds-secures-key-apitox-rights-via-freet-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661909292","title":"Apimeds Pharmaceuticals US - Freet Assigns All Apitox-Related Rights to Apimeds Pharmaceuticals - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2661909292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661909292?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:13","pubTimestamp":1787346814,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290926","title":"Apimeds Pharmaceuticals US - Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation for Apitox - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290926?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:13","pubTimestamp":1787346814,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290973","title":"Apimeds Pharmaceuticals US Gains Apitox Rights in Assignment from South Korea’s FreeT","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290973","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290973?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:13","pubTimestamp":1787346799,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US gains Apitox rights in assignment from South Korea’s FreeTApimeds Pharmaceuticals US entered an Aug. 19, 2026 agreement to acquire Apitox-related rights from South Korea’s F","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL6CbTxm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659612928","title":"Apimeds Net Loss Widens to $20.17 Million in Q2 2026; R&D Expenses Rise 47% to $959,742 vs Year-Ago Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2659612928","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659612928?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:31","pubTimestamp":1786739518,"startTime":"0","endTime":"0","summary":"Apimeds net loss widens to $20.17 million in Q2 2026; R&D expenses rise 47% to $959,742 vs year-ago quarterApimeds posted a net loss of USD 20.17 million for the quarter ended June 30, 2026, widening ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDLbnCjgW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657216669","title":"Apimeds Pharmaceuticals Names Christopher Kim Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2657216669","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657216669?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:26","pubTimestamp":1786055210,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals names Christopher Kim chief scientific officerApimeds Pharmaceuticals US appointed Christopher Kim as chief scientific officer, effective Aug. 5, 2026.Kim will lead scientific,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL7MSD0K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657669423","title":"Apimeds Appoints Chief Scientific Officer to Advance APITOX","url":"https://stock-news.laohu8.com/highlight/detail?id=2657669423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657669423?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:16","pubTimestamp":1786054579,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US, Inc. ( ($APUS) ) has provided an announcement. On August 5, 2026, Apimeds Pharmaceuticals US, Inc. appointed Dr. Christ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apimeds-appoints-chief-scientific-officer-to-advance-apitox?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apimeds-appoints-chief-scientific-officer-to-advance-apitox?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}